Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
95 studies found for:    gastroenterology | Recruiting | Exclude Unknown | United States
Show Display Options
Rank Status Study
1 Recruiting Evaluating a Shared Decision Making Program for Crohn's Disease
Condition: Crohn's Disease
Intervention: Behavioral: Shared Decision Making Program
2 Recruiting Outcome of Colonoscopy Screening and Surveillance
Condition: Gastroenterology
Intervention: Other: Chart Review
3 Recruiting Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index
Conditions: Deglutition Disorders;   Esophageal Diseases;   Eosinophilia
Intervention: Other: assessment of disease activity using the EEsAI
4 Recruiting Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: RHB-104;   Drug: Placebo
5 Recruiting Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Conditions: Autistic Disorder;   Constipation;   Gastrointestinal Diseases
Intervention: Other: Treatment of Functional Constipation by
6 Recruiting Augmentation of Screening Colonoscopy With Fecal Immunochemical Testing
Condition: Colon Cancer
Intervention: Device: Fecal Immunochemical Testing
7 Recruiting Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Conditions: Ampullary Cancer;   Duodenal Cancer;   Bile Duct Cancer;   Bile Duct Disorders;   Gallstones;   Obstructive Jaundice;   Pancreatic Disorders (Noncancerous);   Colorectal Cancer;   Esophageal Cancer;   Barrett's Esophagus;   Gastric Malignancies;   Pancreatic Cancer;   Pediatric Gastroenterology;   Cholangiocarcinoma;   Pancreatic Pseudocysts;   Acute and Chronic Pancreatitis;   Recurrent Pancreatitis;   Cholangitis;   Bile Leak;   Biliary Strictures;   Pancreatic Divisum;   Biliary and Pancreatic Stones;   Choledocholithiasis
8 Recruiting Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: GED-0301;   Drug: Placebo
9 Recruiting Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis;   Biliary Atresia
Intervention: Drug: Oral Vancomycin
10 Recruiting The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
Condition: Gastroparesis
Interventions: Drug: Velusetrag;   Drug: Placebo
11 Recruiting A Placebo- Controlled Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved
Condition: Eosinophilic Esophagitis (EoE)
Interventions: Drug: OBS;   Drug: Placebo
12 Recruiting Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Condition: Non Alcoholic Steatohepatitis (NASH)
Interventions: Drug: Obeticholic Acid;   Drug: Placebo
13 Recruiting Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: CP-690,550
14 Recruiting Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Interventions: Drug: Obeticholic Acid (OCA);   Drug: Placebo
15 Recruiting A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: GED-0301;   Other: Placebo
16 Recruiting An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)
Condition: Eosinophilic Esophagitis (EoE)
Interventions: Drug: Oral Budesonide Suspension (OBS);   Drug: Placebo
17 Recruiting A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
Condition: Short Bowel Syndrome
18 Recruiting Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Interventions: Drug: Mesalamine;   Drug: Placebo
19 Recruiting Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Interventions: Drug: Mesalamine;   Drug: Placebo
20 Recruiting Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis
Conditions: Non-alcoholic Steatohepatitis;   Fibrosis;   Liver Diseases
Interventions: Drug: Emricasan (5 mg);   Drug: Emricasan (50 mg);   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years